#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15796	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2174	720.5	0	.	n	.	0	C451T	SNP	451	451	C	768	768	T	881	T,C,G	406,437,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15796	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2174	720.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1501	1501	C	930	C	888	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28824	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3528	811.0	0	.	n	.	0	T695C	SNP	695	695	T	1023	1023	C	940	C,G	910,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28824	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3528	811.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1966	1966	G	883	G,A	621,235	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28824	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3528	811.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2299	2299	C	910	C,T	874,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28824	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3528	811.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2373	2373	A	956	A,G	914,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28824	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3528	811.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2925	2925	C	911	C,T	881,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28824	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3528	811.0	0	HET	.	.	.	T2085C	.	2085	2085	T	2413	2413	T	947	T,C	702,217	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28824	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3528	811.0	0	HET	.	.	.	G256C	.	256	256	G	584	584	G	929	G,C	613,207	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1950	folP	855	855	100.0	folP.l6.c4.ctg.1	1565	123.3	1	SNP	p	R229S	1	.	.	685	687	AGC	971	973	AGC	200;202;203	A;G,A;C	194;193,1;196	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5954	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3471	170.5	1	SNP	p	S91F	1	.	.	271	273	TTC	564	566	TTC	198;194;196	T;T;C	189;185;185	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5954	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3471	170.5	1	SNP	p	D95G	1	.	.	283	285	GGC	576	578	GGC	192;191;188	G;G,C;C	176;175,3;178	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5954	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3471	170.5	1	SNP	p	G95N	0	.	.	283	285	GGC	576	578	GGC	192;191;188	G;G,C;C	176;175,3;178	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1780	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1395	126.4	1	SNP	p	G45D	0	.	.	133	135	GGC	498	500	GGC	233;234;233	G;G;C	216;220;219	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	830	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	942	87.4	0	.	n	.	0	A197.	DEL	197	197	A	479	479	A	194	A	180	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5702	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3001	188.7	1	SNP	p	D86N	0	.	.	256	258	GAC	546	548	GAC	223;222;222	G;A;C	216;211;216	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5702	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3001	188.7	1	SNP	p	R87W	0	.	.	259	261	CGT	549	551	CGT	223;225;226	C;G;T	218;221;215	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5702	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3001	188.7	1	SNP	p	R87I	0	.	.	259	261	CGT	549	551	CGT	223;225;226	C;G;T	218;221;215	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5702	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3001	188.7	1	SNP	p	S87R	1	.	.	259	261	CGT	549	551	CGT	223;225;226	C;G;T	218;221;215	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5702	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3001	188.7	1	SNP	p	S88P	0	.	.	262	264	TCC	552	554	TCC	228;233;232	T;C;C	221;226;226	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4114	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2676	152.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1543	1545	GGC	185;184;182	G;G;C	180;179;175	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4292	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2230	189.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1143	1145	GCC	226;226;227	G;C;C,A	214;216;213,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4292	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2230	189.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1146	1148	ATG	225;225;228	A,T;T;G,C	213,1;215;216,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4292	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2230	189.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1158	1160	ACC	228;233;235	A;C;C	217;226;225	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4292	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2230	189.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1158	1160	ACC	228;233;235	A;C;C	217;226;225	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4292	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2230	189.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1659	1661	ACC	212;212;210	A;C;C	199;201;200	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4292	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2230	189.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1713	1715	GCG	195;196;196	G;C;G	191;193;193	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4292	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2230	189.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1713	1715	GCG	195;196;196	G;C;G	191;193;193	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4292	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2230	189.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1836	1838	GGT	174;171;170	G,A;G;T,C	162,2;162;155,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4292	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2230	189.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1845	1847	AGC	165;165;164	A,G;G;C	147,3;152;153	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4292	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2230	189.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1863	1865	CCG	120;121;125	C,G;C,G;G	107,4;111,1;108	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6166	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3036	201.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1545	1547	CCG	204;205;202	C;C;G	191;199;190	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2500	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1872	132.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	589	589	C	168	C	158	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2998	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1490	198.8	0	.	p	.	0	Q143K	NONSYN	427	429	CAA	687	689	AAA	206;207;207	A,C;A;A	188,14;203;201	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2998	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1490	198.8	0	.	p	.	0	G210R	NONSYN	628	630	GGA	888	890	AGA	240;240;244	A,G;G;A	230,6;230;239	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2998	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1490	198.8	0	.	p	.	0	S217G	NONSYN	649	651	AGT	909	911	GGT	254;256;255	G,A;G;T	244,5;251;246	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2998	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1490	198.8	1	SNP	p	G120K	1	.	.	358	360	AAG	618	620	AAG	217;216;217	A;A;G,T	207;211;203,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2998	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1490	198.8	1	SNP	p	A121N	1	.	.	361	363	AAC	621	623	AAC	218;220;221	A,G;A;C	206,6;215;212	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2998	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1490	198.8	1	SNP	p	N121D	0	.	.	361	363	AAC	621	623	AAC	218;220;221	A,G;A;C	206,6;215;212	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10514	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4683	222.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1214	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1092	110.4	1	SNP	p	V57M	1	.	.	169	171	ATG	503	505	ATG	240;243;240	A;T;G	233;234;230	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
